Seven Bridges Genomics Seven Bridges, ZS Partner for Multiomics Analytics in Drug Development The partners hope to provide scalable "one-stop" analytics convenience to ZS's pharmaceutical clients. Seven Bridges Raises $15M in First Closing of Series C The bioinformatics firm, which did not identify the new investor, expects to close the rest of the $30 million round later this quarter. People in the News: New Appointments at Adaptive Biotechnologies, BD, Seven Bridges, More New Products Posted to GenomeWeb: CRISPR QC, Cardea Bio, Seven Bridges, Congenica, More In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More News items for the week of June 8, 2020. Jun 11, 2020 Seven Bridges Building Research Platform for PanCAN Jun 2, 2020 Seven Bridges Joins International Genomic Cancer Research Effort Dec 20, 2019 People in the News: Gautam Kollu, Michael Bigda, Peter Nell, Ted Tisch, More Oct 17, 2019 Variant Detection Gets Boost From Graph Genomes, De Novo Assemblies Premium Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.